Rokx C - Search Results

1

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review.

Debrabander Q, Hensley KS, Psomas CK, Bramer W, Mahmoudi T, van Welzen BJ, Verbon A, Rokx C. Debrabander Q, et al. Among authors: rokx c. J Virus Erad. 2023 Aug 19;9(3):100342. doi: 10.1016/j.jve.2023.100342. eCollection 2023 Sep. J Virus Erad. 2023. PMID: 37663575 Free PMC article. Review.

2

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection.

Gharbharan A, Jordans CCE, GeurtsvanKessel C, den Hollander JG, Karim F, Mollema FPN, Stalenhoef-Schukken JE, Dofferhoff A, Ludwig I, Koster A, Hassing RJ, Bos JC, van Pottelberge GR, Vlasveld IN, Ammerlaan HSM, van Leeuwen-Segarceanu EM, Miedema J, van der Eerden M, Schrama TJ, Papageorgiou G, Te Boekhorst P, Swaneveld FH, Mueller YM, Schreurs MWJ, van Kampen JJA, Rockx B, Okba NMA, Katsikis PD, Koopmans MPG, Haagmans BL, Rokx C, Rijnders BJA. Gharbharan A, et al. Among authors: rokx c. Nat Commun. 2021 May 27;12(1):3189. doi: 10.1038/s41467-021-23469-2. Nat Commun. 2021. PMID: 34045486 Free PMC article. Clinical Trial.

3

Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020.

Simões D, Stengaard AR, Combs L, Raben D; EuroTEST COVID-19 impact assessment consortium of partners. Simões D, et al. Euro Surveill. 2020 Nov;25(47):2001943. doi: 10.2807/1560-7917.ES.2020.25.47.2001943. Euro Surveill. 2020. PMID: 33243354 Free PMC article.

4

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study.

TenoRes Study Group. TenoRes Study Group. Lancet Infect Dis. 2016 May;16(5):565-575. doi: 10.1016/S1473-3099(15)00536-8. Epub 2016 Jan 29. Lancet Infect Dis. 2016. PMID: 26831472 Free PMC article.

5

Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients.

Rokx C, van der Ende ME, Verbon A, Rijnders BJ. Rokx C, et al. Clin Infect Dis. 2013 Nov;57(10):1497-9. doi: 10.1093/cid/cit517. Epub 2013 Aug 2. Clin Infect Dis. 2013. PMID: 23912848

6

Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapy.

Rokx C, Verbon A, Rijnders BJ. Rokx C, et al. HIV Med. 2014 Nov;15(10):611-4. doi: 10.1111/hiv.12157. Epub 2014 Apr 16. HIV Med. 2014. PMID: 24738660 Free article.

7

The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patients.

Rokx C, Blonk M, Verbon A, Burger D, Rijnders BJ. Rokx C, et al. J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):36-9. doi: 10.1097/QAI.0000000000000363. J Acquir Immune Defic Syndr. 2015. PMID: 25247434 Clinical Trial.

8

Increased virological failure in naive HIV-1-infected patients taking lamivudine compared with emtricitabine in combination with tenofovir and efavirenz or nevirapine in the Dutch nationwide ATHENA cohort.

Rokx C, Fibriani A, van de Vijver DA, Verbon A, Schutten M, Gras L, Rijnders BJ; AIDS Therapy Evaluation in the Netherlands National Observational Cohort. Rokx C, et al. Clin Infect Dis. 2015 Jan 1;60(1):143-53. doi: 10.1093/cid/ciu763. Epub 2014 Oct 1. Clin Infect Dis. 2015. PMID: 25273080

9

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort.

Rokx C, Fibriani A, van de Vijver D, Verbon A, Schutten M, Gras L, Rijnders BJ. Rokx C, et al. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19491. doi: 10.7448/IAS.17.4.19491. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394000 Free PMC article.

10

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study.

Rokx C, Blonk M, Verbon A, Burger D, Rijnders BJ. Rokx C, et al. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19789. doi: 10.7448/IAS.17.4.19789. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397533 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters